A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement

OBJECTIVE: To explore the role of genetic testing of VKORC1 and CYP2C9 in determining the dosage of warfarin after aortic valve replacement. METHODS: A total of 172 patients receiving warfarin after aortic valve replacement were divided into a control group (n = 86) and an experimental (n = 86) grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Zhang, Congcong, Gu, Chengxiong, Yu, Yang, Li, Jingxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019963/
https://www.ncbi.nlm.nih.gov/pubmed/35439929
http://dx.doi.org/10.1186/s12872-022-02620-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019963/
https://www.ncbi.nlm.nih.gov/pubmed/35439929
http://dx.doi.org/10.1186/s12872-022-02620-x

Ejemplares similares